Skip to Content


In the US, Synribo (omacetaxine systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Chronic Myelogenous Leukemia.

US matches:

Ingredient matches for Synribo


Omacetaxine Mepesuccinate is reported as an ingredient of Synribo in the following countries:

  • United States

← International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.